株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の静注用鉄剤市場

Global Intravenous (IV) Iron Drugs Market: Industry Analysis & Outlook 2017-2021

発行 Koncept Analytics 商品コード 230700
出版日 ページ情報 英文 64 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.21円で換算しております。
Back to Top
世界の静注用鉄剤市場 Global Intravenous (IV) Iron Drugs Market: Industry Analysis & Outlook 2017-2021
出版日: 2017年05月17日 ページ情報: 英文 64 Pages
概要

当レポートでは、世界の静注用鉄剤市場について調査分析し、地域別の市場動向に焦点を当てて、概要、市場力学、競合情勢、主要企業プロファイルなど、体系的な情報を提供しています。

第1章 人体における鉄分:イントロダクション

  • 静注用鉄剤の適用分野
  • 鉄分不足:貧血
  • 貧血治療の静注療法
  • 静注用鉄剤の種類

第2章 世界の鉄剤製品市場の分析

  • 市場:金額別
  • 市場シェア:セグメント別

第3章 世界の静注用鉄剤市場の分析

  • 市場:金額別
  • 市場:製品別
  • 市場シェア:製品別

第4章 地域の静注用鉄剤市場の分析

  • 欧州
  • 米国

第5章 市場力学

  • 成長促進要因
  • 動向
  • 課題

第6章 競合情勢

  • 製品の比較

第7章 企業プロファイル

第8章 市場の見通し

  • 市場予測
  • 予測手法

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Iron is among the vital minerals present in the human body. It is one of the components of hemoglobin, the substance present in red blood cells that carries oxygen throughout the body through blood, and oxygen is further utilized by the cells to produce energy required to perform all the required functions. Therefore, decline in the body's supply of iron can lead to severe problems. The balance of iron in the body primarily is a combined result of three dynamics- intake, losses and metabolic demand.

Intravenous (I.V.) treatment, in a broad sense, covers all the types of medications delivered intravenously, i.e. directly into the vein, through intravenous (I.V.) drip. Compared to the other routes of infusing medications, the intravenous route is the fastest way to deliver fluids and medications throughout the body. Also, this method ensures 100% bioavailability, which means that the chemicals delivered are fully absorbed by the body.

The report “Global I.V. Iron Drugs Market” provides a comprehensive study of iron product market and I.V. iron market globally. It also provides detailed information for key regional markets of I.V iron industry. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry, Galenica Group, AMAG Pharmaceuticals and Allergan are being profiled. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth.

The key factors driving the growth of I.V. iron drugs market are growing ageing population, growing urbanization, increase in number of dialysis cases, rising healthcare expenditure and increasing life expectancy rate. Some of the noteworthy trends and developments of this industry are paradigm shift from oral iron drugs to intravenous iron drugs and introduction of first generation drugs InFeD and Dexeferrum. However, the expansion of the market is hindered by potential risks of I.V. iron.

Table of Contents

1. I.V. Iron Market - An Overview

  • 1.1. Iron in Human Body: An Introduction
  • 1.2. I.V. Iron Application Areas
  • 1.3. I.V. Iron Applications in Nephrology
  • 1.4. Iron Deficiency - Anemia
  • 1.5. Iron Therapies for Anemia Treatment

2. Global Iron Product Market Analysis

  • 2.1. Global Iron Product Market by Value
  • 2.2. Global Iron Product Market Forecast by Value
  • 2.3. Global Iron Product Market by Segments
<>3. Global I.V. Iron Drugs Market Analysis
  • 3.1. Global I.V. Iron Drugs Market by Value
  • 3.2. Global I.V. Iron Drugs Market Forecast by Value
  • 3.3. Global I.V. Iron Drugs Market by Product Category
  • 3.4. Global I.V. Iron Drugs Market Share by Product Category
  • 3.5. Global I.V. Iron Drugs Market Share by Segments

4. Regional Market Analysis

  • 4.1. The US
    • 4.1.1. The US I.V. Iron Drug Market by Value
    • 4.1.2. The US I.V. Iron Drug Market Forecast by Value
    • 4.1.2. The US I.V. Iron Drug Market by Product Category
    • 4.1.3. The US I.V. Iron Drug Market Share by Product Category
    • 4.1.4. The US Non-dialysis I.V. Iron Drug Market by Volume
    • 4.1.5. The US Non-dialysis I.V. Iron Drug Market Forecast by Volume
    • 4.1.6. The US Non-dialysis I.V. Iron Drug Market Share by Product
  • 4.2. Europe
    • 4.2.1. European I.V. Iron Drug Market by Value
    • 4.2.2. European I.V. Iron Drug Market Forecast by Value
    • 4.2.3. European I.V. Iron Drug Market by Product Category
    • 4.2.4. European I.V. Iron Drug Market Share by Product Category

5. Market Dynamics

  • 5.1. Growth Drivers
    • 5.1.1. Growing Ageing Population
    • 5.1.2. Growing Urbanization
    • 5.1.3. Increase in Number of Dialysis Cases
    • 5.1.4. Rising Healthcare Expenditure
    • 5.1.5. Increasing Life Expectancy Rate
  • 5.2. Market Trends
    • 5.2.1. Paradigm Shift from Oral Iron Drugs to Intravenous Iron Drugs
    • 5.2.2. Introduction of First Generation Drugs InFeD and Dexeferrum
  • 5.3. Challenges
    • 5.3.1. Potential Risks of I.V. Iron

6. Competitive Landscape

  • 6.1. Comparison between Injectafer, Venofer, INFeD and Feraheme

7. Company Profiles

  • 7.1. Galenica Group
    • 7.1.1. Business Overview
    • 7.1.2. Financial Overview
    • 7.1.3. Business Strategies
  • 7.2. AMAG Pharmaceuticals
    • 7.2.1. Business Overview
    • 7.2.2. Financial Overview
    • 7.2.3. Business Strategies
  • 7.3. Allergan plc.
    • 7.3.1. Business Overview
    • 7.3.2. Financial Overview
    • 7.3.3. Business Strategies

List of Charts

  • Risk Factors for CKD
  • Global Iron Product Market by Value (2011-2016)
  • Global Iron Product Market Forecast by Value (2017-2021)
  • Global Iron Product Market by Segments (2016)
  • Global I.V. Iron Drugs Market by Value (2010-2016)
  • Global I.V. Iron Drugs Market Forecast by Value (2017-2021)
  • Global I.V. Iron Drugs Market by Product Category (2010-2016)
  • Global I.V. Iron Drugs Market Share by Product Category (2016)
  • Global I.V. Iron Drugs Market Share by Segments (2016)
  • The US I.V. Iron Drug Market by Value (2010-2016)
  • The US I.V. Iron Drug Market Forecast by Value (2017-2021)
  • The US I.V. Iron Drug Market by Product Category (2010-2016)
  • The US I.V. Iron Drug Market Share by Product Category (2016)
  • The US Non-dialysis I.V. Iron Drug Market by Volume (2010-2016)
  • The US Non-dialysis I.V. Iron Drug Market Forecast by Volume (2010-2016)
  • The US Non-dialysis I.V. Iron Drug Market Share by Product (2016)
  • European I.V. Iron Drug Market by Value (2010-2016)
  • European I.V. Iron Drug Market Forecast by Value (2017-2021)
  • European I.V. Iron Drug Market by Product Category (2010-2016)
  • European I.V. Iron Drug Market Share by Product Category (2016)
  • Global Ageing Population (2007-2016)
  • Global Urban Population (2007-2016)
  • Global Dialysis Patients (2012-2016)
  • Global Dialysis Patients by Type (2016)
  • Global Healthcare Expenditure (2007-2016)
  • Global Life Expectancy Rate (2007-2016)
  • Comparison between Injectafer, Venofer, INFeD and Feraheme
  • Galenica's Net Sales Share by Business Segments (2016)
  • Galenica's Net Sales Share by Region (2016)
  • Galenica's Net Sales and Net Profit (2012-2016)
  • AMAG Pharmaceuticals' Revenue and Net Income (2012-2016)
  • Allergan Plc.'s Revenue Business Segment (2016)
  • Allergan Plc.'s Revenue and Net Income (2012-2016)
Back to Top